ZYME vs MNKD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

ZYME

47.6
AI Score
VS
MNKD Wins

MNKD

48.1
AI Score

Investment Advisor Scores

ZYME

48score
Recommendation
HOLD

MNKD

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ZYME MNKD Winner
Forward P/E 21.9298 41.3223 ZYME
PEG Ratio 0 4.3866 Tie
Revenue Growth -91.1% 15.1% MNKD
Earnings Growth 0.0% -34.9% ZYME
Tradestie Score 47.6/100 48.1/100 MNKD
Profit Margin -126.3% -6.6% MNKD
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

ZYME 1M: -11.5% · 3M: -16.3% MNKD 1M: -9.4% · 3M: +37.7%

Current Technical Phase

ZYME

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.3%), weak momentum, RSI 40

RSI (14): 40.5 · Price: $22.42

MNKD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.9 · Price: $3.87

Fundamentals Snapshot

Metric ZYME MNKD
Market Cap
Forward P/E 26.3 17.5
Trailing P/E
Revenue (TTM)
Revenue Growth -0.9% 0.2%
Gross Margin -0.7% 0.8%
Operating Margin -19.6% 0.0%
EPS -1.37 -0.07
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MNKD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.